ストックスクリーナーアプリを入手
4.27
26.71%
0.90
アフターアワーズ：
4.26
-0.010
-0.23%
Ironwood Pharmaceuticals Inc (IRWD) 最新ニュース
Ironwood Pharmaceuticals Inc. (IRWD) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Ironwood Pharmaceuticals: Market Response to Legal Settlement - StocksToTrade
Stock soars at Boston biotech after it cuts price of IBS drug - The Business Journals
Ironwood Finds a New Floor as LINZESS Net Pricing Turns Into a Growth Lever - Investing.com
Ironwood Pharma (IRWD) Surges on Strong FY26 Guidance and Pipeline Updates - GuruFocus
Ironwood Pharmaceuticals Stock (IRWD) Opinions on 2026 Financial Guidance - Quiver Quantitative
Ironwood Pharmaceuticals Stock Soars as Drug-Price Cut Boosts Prospects for 2026 - Barron's
Ironwood Pharmaceuticals stock soars on strong 2026 guidance - Investing.com
Stock Traders Buy High Volume of Ironwood Pharmaceuticals Call Options (NASDAQ:IRWD) - MarketBeat
Ironwood boosts outlook on AbbVie's Linzess (update) (IRWD) - Seeking Alpha
Ironwood Pharmaceuticals (NASDAQ:IRWD) Hits New 12-Month HighHere's Why - MarketBeat
Ironwood Pharmaceuticals, Baidu, Vertiv Holdings And Other Big Stocks Moving Higher On Friday - Benzinga
Why Did Ironwood Pharmaceuticals Stock Skyrocket Today? - Stocktwits
Ironwood’s Recent Move: A Catalyst for Change? - timothysykes.com
Why Is IRWD Stock Soaring Over 30% Premarket? 2026 Revenue Outlook Beats Estimates - Tokenist
Ironwood (IRWD) Focuses on Financial Growth and Drug Development - GuruFocus
Ironwood Pharmaceuticals, Inc. Maintains Earnings Guidance for Year 2025 and Provides Earnings Guidance for Year 2026 - marketscreener.com
Ironwood Pharmaceuticals (IRWD) Projects Strong Revenue Growth f - GuruFocus
Ironwood beats on 2026 outlook thanks to AbbVie-partnered Linzess - MSN
Ironwood Pharma Provides FY26 Outlook, Maintains Full Year Outlook - Nasdaq
Ironwood forecasts 2026 LINZESS sales to exceed $1.1 billion - Investing.com
Ironwood Pharmaceuticals Maintains FY 2025 Financial Guidance and Announces FY 2026 Financial Guidance - TradingView — Track All Markets
Why is Ironwood (IRWD) up 24.9% since last earnings report? - MSN
Ironwood Pharmaceuticals expresses gratitude and drives GI health progress - Traders Union
Ironwood Pharmaceuticals (NASDAQ:IRWD) Stock Price Up 4.8%Still a Buy? - MarketBeat
Ironwood Pharma (NASDAQ:IRWD) Nasdaq composite Biotech Watch - Kalkine Media
Ironwood Pharmaceuticals (NASDAQ:IRWD) Share Price Crosses Above Two Hundred Day Moving AverageHere's Why - MarketBeat
Ironwood Pharmaceuticals' VectivBio Settles Ferring Lawsuit Through License Amendment - marketscreener.com
Boston biotech settles lawsuit alleging misappropriation of GLP-2 analog intellectual property - The Business Journals
Ironwood gains after settling Ferring lawsuit (IRWD:NASDAQ) - Seeking Alpha
Ironwood Pharmaceuticals amends license deal with Ferring, settles litigation By Investing.com - Investing.com UK
Ironwood Pharmaceuticals, Inc.(NasdaqGS:IRWD) added to S&P Biotechnology Select Industry Index - marketscreener.com
How Ironwood Pharmaceuticals Inc. (I76) stock reacts to Fed tighteningOil Prices & Free Accurate Trade Setup Notifications - Улправда
Geopolitics Watch: Why Ironwood Pharmaceuticals Inc. stock is rated strong buyAnalyst Downgrade & Stepwise Trade Signal Guides - Улправда
Why Ironwood Pharmaceuticals Inc. stock is rated strong buyJuly 2025 Update & High Accuracy Trade Signal Alerts - Улправда
Ironwood Pharmaceuticals Earnings Notes - Trefis
Published on: 2025-12-19 06:52:33 - Улправда
Ironwood Pharmaceuticals (NASDAQ:IRWD) Shares Down 3.7%Here's Why - MarketBeat
What drives Ironwood Pharmaceuticals Inc stock priceMarket Entry Points & High Yield Portfolio Growth - earlytimes.in
Ironwood Pharmaceuticals (IRWD) director and 10% owner reports new share grant - Stock Titan
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Receives Average Recommendation of "Hold" from Brokerages - MarketBeat
Ironwood Pharmaceuticals announces workforce reduction - MSN
Ironwood Pharma Board Member Resigns for New Role - MSN
Ironwood Pharma drops 7% as FY 2025 revenue guidance below consensus - MSN
Armistice Capital LLC Acquires 2,450,000 Shares of Ironwood Pharmaceuticals, Inc. $IRWD - MarketBeat
Why Is Ironwood (IRWD) Up 24.9% Since Last Earnings Report? - sharewise.com
Ironwood Pharmaceuticals (NASDAQ:IRWD) Trading Up 6%What's Next? - MarketBeat
Ironwood Pharmaceuticals (IRWD) price target increased by 38.89% to 2.55 - MSN
Ironwood Pharma’s LINZESS® Price Set by HHS - MSN
Can Ironwood Pharmaceuticals Stock Recover If Markets Fall? - Trefis
Ironwood Pharmaceuticals (IRWD) Price Target Increased by 38.89% to 2.55 - Nasdaq
Can Ironwood Pharmaceuticals Stock Hold Up When Markets Turn? - Trefis
Ironwood Pharmaceuticals (NASDAQ:IRWD) Stock Price Down 5%Time to Sell? - MarketBeat
Is Ironwood Pharmaceuticals Inc. (I76) stock cheap by valuation metricsOptions Play & Scalable Portfolio Growth Ideas - Newser
Can Ironwood Pharmaceuticals Inc. stock sustain institutional interestProfit Target & Fast Gaining Stock Strategy Reports - Newser
Zacks Research Analysts Increase Earnings Estimates for IRWD - MarketBeat
Why Ironwood Pharmaceuticals Inc. (I76) stock could be next leaderJuly 2025 Macro Moves & Community Verified Swing Trade Signals - Newser
How dovish Fed policy supports Ironwood Pharmaceuticals Inc. (I76) stockRecession Risk & Weekly High Return Forecasts - Newser
Irritable Bowel Syndrome (IBS) Treatment Market Competition Analysis 2025: How Players Are Shaping Growth - EIN News
IRWD SEC FilingsIronwood 10-K, 10-Q, 8-K Forms - Stock Titan
Is Ironwood Pharmaceuticals, Inc. overvalued or undervalued? - Markets Mojo
2.19%
0.08%
大文字化:
|
ボリューム (24 時間):